PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
19358180-0	2009	Simvastatin impairs smad-3 phosphorylation and modulates transforming growth factor beta1-mediated activation of intestinal fibroblasts.	Simvastatin	0-11	SMAD family member 3	Homo sapiens	20-26	
23817018-10	2013	RESULTS: Sim significantly attenuated the TGF-beta1-induced decrease in E-Cad levels and elevated the levels of alpha-SMA, Vi and FN via the suppression of Smad2 and Smad3 phosphorylation.	Simvastatin	9-12	SMAD family member 3	Homo sapiens	166-171	
30220377-4	2018	We aimed to assess whether simvastatin-mediated reduction in TGF-beta1-augmented profibrotic response involves reduction in phospho-SMAD2/3 owing to activation of protein-phosphatase in hVFs.	Simvastatin	27-38	SMAD family member 3	Homo sapiens	132-139	
24471776-11	2014	The TGF-beta1-induced Smad2 and Smad3 phosphorylation levels were abrogated by simvastatin pretreatment.	Simvastatin	79-90	SMAD family member 3	Homo sapiens	32-37	
19358180-11	2009	Simvastatin pretreatment inhibited TGF-beta1-mediated phosphorylation of smad-3.	Simvastatin	0-11	SMAD family member 3	Homo sapiens	73-79	
19358180-12	2009	CONCLUSION: Simvastatin abrogates TGF-beta1-mediated intestinal fibroblast activation by inhibition of smad-3 phosphorylation.	Simvastatin	12-23	SMAD family member 3	Homo sapiens	103-109